Child's Nervous System

, Volume 35, Issue 5, pp 775–778 | Cite as

Drug-resistant epilepsy in Indian children at a tertiary-care public hospital

  • Prarthana KharodEmail author
  • Devendra Mishra
  • Monica Juneja
Original Article



Drug-resistant epilepsy (DRE), a condition in which seizures persist and seizure freedom is unlikely to be attained with further manipulation of anti-epileptic drugs, occurs in around 20% of children with epilepsy. This study was conducted with the aim to study the profile of Indian children with resistant epilepsy, using the new consensus definition of DRE.


All children who had been attending the Pediatric Neurology Clinic regularly for at least 6 months were reviewed between April and September 2015. Children fulfilling the ILAE Commission on Therapeutic Strategies Consensus Proposal definition of DRE were enrolled for the study. After informed consent, the records were reviewed and disease-related data was entered in the study form. The data were analyzed to determine etiological factors and treatment gaps in children with DRE.


Fifty children (12 females) with median (range) age of 90 (11–159) months and follow-up of 17.9 (8.5–20) months were enrolled. The mean (standard deviation) age at seizure onset and start of anti-epileptic drugs (AED) were 1.8 (2.11) and 2.1 (2.09) years, respectively. The median (range) number of anti-epileptic drugs that had been tried in these children was 5 (2–9), with drug side effects leading to discontinuation in 8 (16%) patients. Only two patients had tried ketogenic diet; vagal nerve stimulation and epilepsy surgery had not been tried by any family, despite recommendation by the physicians in 7 children.


Majority of Indian children with DRE have onset of epilepsy in early infancy, and are infrequently provided access to newer non-pharmacological measures.


Difficult-to-control epilepsy Intractable epilepsy Pharmaco-resistance 


Author contributions

PKP: assisted in clinically managing the patients and study design, compiled the data, and prepared the initial draft of the manuscript. DM: designed and initiated the study, clinically managed the patients, did the statistical analysis, prepared the final draft of the manuscript, and would be the guarantor. MJ: provided important intellectual inputs in the study design, conduct, and manuscript preparation. All authors approved the final manuscript for submission.

Compliance with ethical standards

Conflict of interest

All authors declare that there were no conflict of interest.


  1. 1.
    Berg AT, Levy SL, Testa FM, D’Souza R (2009) Remission of epilepsy after two drug failures in children: a prospective study. Ann Neurol 65:510–519CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Chawla S, Aneja S, Kashyap R, Mallika V (2002) Etiology and clinical predictors of intractable epilepsy. Pediatr Neurol 27:186–191CrossRefPubMedGoogle Scholar
  3. 3.
    Dash D, Aggarwal V, Joshi R, Padma MV, Tripathi M (2015) Effect of reduction of antiepileptic drugs in patients with drug-refractory epilepsy. Seizure 27:25–29CrossRefPubMedGoogle Scholar
  4. 4.
    Go C, Snead OC (2008) Pharmacologically intractable epilepsy in children: diagnosis and preoperative evaluation. Neurosurg Focus 25:2CrossRefGoogle Scholar
  5. 5.
    Gururaj A, Sztriha L, Hertecant J, Eapen V (2006) Clinical predictors of intractable childhood epilepsy. J Psychosom Res 61:343–347CrossRefPubMedGoogle Scholar
  6. 6.
    Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Hauser WA, Mathern G et al (2010) Definition of drug-resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51:1069–1077CrossRefGoogle Scholar
  7. 7.
    Oldham MS, Horn PS, Tsevat J, Standridge S (2015) Costs and clinical outcomes of epilepsy surgery in children with drug-resistant epilepsy. Pediatr Neurol 53:216–220CrossRefPubMedGoogle Scholar
  8. 8.
    Perucca E (2005) Can drug-resistance in epilepsy be minimized? Challenging commonly held beliefs. Epileptic Disord 7:14–21Google Scholar
  9. 9.
    Sánchez Fernández I, An S, Loddenkemper T (2015) Pediatric refractory epilepsy: a decision analysis comparing medical versus surgical treatment. Epilepsia 56:263–272CrossRefPubMedGoogle Scholar
  10. 10.
    Singhvi JP, Sawhney IMS, Lal V, Pathak A, Prabhakar S (2000) Profile of intractable epilepsy in a tertiary referral center. Neurol India 48:351–356PubMedGoogle Scholar
  11. 11.
    Tripathi M, Padhy UP, Vibha D, Bhatia R, Padma Srivastava MV, Singh MB, Prasad K, Chandra SP (2011) Predictors of refractory epilepsy in North India: a case-control study. Seizure 20:779–783CrossRefPubMedGoogle Scholar
  12. 12.
    Udani VP, Dharnidharka V, Nair A, Oka M (1993) Difficult to control epilepsy in childhood--a long term study of 123 cases. Indian Pediatr 30:1199–1206PubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Prarthana Kharod
    • 1
    • 2
    Email author
  • Devendra Mishra
    • 1
  • Monica Juneja
    • 1
  1. 1.Department of Pediatrics, Lok Nayak Hospital, Maulana Azad Medical CollegeUniversity of DelhiNew DelhiIndia
  2. 2.Department of PediatricsGCS Medical CollegeAhmedabadIndia

Personalised recommendations